DYNAVAX TECHNOLOGIES CORP — Director's Dealing 2024

Feb 20, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: DYNAVAX TECHNOLOGIES CORP (DVAX)
CIK: 0001029142
Period of Report: 2024-02-15

Reporting Person: MacDonald Kelly (SVP and CFO)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-02-15	Stock Options (Right to Buy)	$12.48	A	65000	Acquired	2031-02-15	Common Stock (65000)	Direct
2024-02-15	Restricted Stock Unit	$	A	46430	Acquired		Common Stock (46430)	Direct

Footnotes

F1: Code A: Grant, award or other acquisition

F2: This option grant will vest over three (3) years with one third (1/3) of the shares subject to the option vesting twelve months after the grant date of
February 15, 2024, and one thirty-sixth (1/36) of the shares subject to the option vesting each month thereafter.

F3: Each RSU represents a contingent right to receive one share of common stock. The RSUs vest over three years with 1/3 vesting on each annual
anniversary of February 15, 2024.